tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Pacira Biosciences Inc

PCRX
Add to Watchlist
26.410USD
-0.560-2.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.04BMarket Cap
209.75P/E TTM

Pacira Biosciences Inc

26.410
-0.560-2.08%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

PCRX Financials

See Pacira Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Pacira Biosciences Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/0.65
Revenue / Forecast
--/190.82M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
726.41M
3.63%
EPS(YoY)
0.16
107.33%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-30.70%0.07
-88.91%0.04
103.97%0.12
-126.07%-0.11
-46.15%0.10
-35.14%0.35
-1429.36%-3.11
-26.83%0.41
145.42%0.19
343.27%0.54
--0.23
--0.56
---0.43
---0.22
--0.57
----
----
----
----
----
Revenue
5.00%177.38M
5.14%196.87M
6.49%179.52M
1.73%181.10M
1.08%168.92M
3.32%187.25M
2.83%168.57M
5.05%178.02M
4.23%167.12M
5.40%181.24M
-2.11%163.93M
0.03%169.47M
1.49%160.34M
8.02%171.96M
31.12%167.47M
24.94%169.41M
32.74%157.99M
21.55%159.19M
8.71%127.72M
79.58%135.59M
Net Profit
-39.40%2.92M
-89.79%1.64M
103.79%5.43M
-125.66%-4.85M
-46.41%4.81M
-35.50%16.04M
-1421.29%-143.47M
-26.69%18.89M
145.96%8.98M
346.19%24.87M
1666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-96.92%-10.10M
-103.92%-693.00K
4.17%19.88M
-34.15%6.83M
-135.34%-5.13M
-86.43%17.66M
362.50%19.08M
Net Margin
-42.29%1.64%
-90.29%0.83%
103.56%3.03%
-125.23%-2.68%
-46.98%2.85%
-37.57%8.57%
-1384.87%-85.11%
-30.22%10.61%
144.10%5.37%
333.57%13.72%
--6.62%
--15.20%
---12.18%
---5.87%
--5.26%
----
----
----
----
----
Gross Margin
0.26%71.40%
1.70%72.26%
6.54%72.93%
3.63%69.53%
12.93%71.21%
8.01%71.05%
2.14%68.45%
6.32%67.09%
4.23%63.06%
18.18%65.78%
--67.01%
--63.10%
--60.50%
--55.66%
--63.56%
----
----
----
----
----
Debt to assets ratio
-17.26%30.42%
-21.91%29.42%
-24.78%29.03%
5.53%37.76%
11.88%36.77%
13.54%37.68%
12.91%38.60%
0.04%35.78%
-9.59%32.86%
-19.09%33.18%
--34.19%
--35.77%
--36.35%
--41.01%
--43.12%
----
----
----
----
----
Income Statement
Revenue
5.00%177.38M
5.14%196.87M
6.49%179.52M
1.73%181.10M
1.08%168.92M
3.32%187.25M
2.83%168.57M
5.05%178.02M
4.23%167.12M
5.40%181.24M
-2.11%163.93M
0.03%169.47M
1.49%160.34M
8.02%171.96M
31.12%167.47M
24.94%169.41M
32.74%157.99M
21.55%159.19M
8.71%127.72M
79.58%135.59M
Operating profit
-43.44%4.63M
-87.16%3.79M
-34.61%14.35M
-66.96%10.23M
-45.90%8.18M
-13.05%29.53M
4.14%21.95M
33.15%30.98M
67.65%15.12M
138.49%33.97M
-3.22%21.08M
76.55%23.26M
-58.51%9.02M
-68.92%14.24M
-29.11%21.78M
-62.34%13.18M
1.97%21.73M
103.21%45.82M
67.75%30.72M
457.95%34.99M
Net Profit
-39.40%2.92M
-89.79%1.64M
103.79%5.43M
-125.66%-4.85M
-46.41%4.81M
-35.50%16.04M
-1421.29%-143.47M
-26.69%18.89M
145.96%8.98M
346.19%24.87M
1666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-96.92%-10.10M
-103.92%-693.00K
4.17%19.88M
-34.15%6.83M
-135.34%-5.13M
-86.43%17.66M
362.50%19.08M
Balance Sheet
Current assets
-32.24%514.96M
-26.46%547.97M
-18.44%562.75M
17.94%745.61M
39.93%759.96M
46.11%745.13M
54.27%689.97M
47.26%632.21M
44.40%543.11M
2.34%509.99M
-16.15%447.25M
-18.41%429.32M
-43.61%376.11M
-42.46%498.33M
-35.14%533.41M
-33.61%526.21M
-7.39%667.02M
32.91%866.05M
24.88%822.35M
73.88%792.58M
Total current liabilities
-65.44%108.79M
-61.09%120.59M
-65.05%107.08M
237.86%313.16M
236.81%314.73M
218.25%309.92M
227.14%306.40M
-14.89%92.69M
-5.32%93.44M
-34.10%97.38M
-28.79%93.66M
-18.22%108.91M
-67.65%98.70M
-71.64%147.77M
-41.75%131.53M
-41.77%133.18M
31.45%305.07M
105.71%521.12M
161.72%225.79M
224.01%228.69M
Total assets
-23.83%1.21B
-18.58%1.26B
-14.73%1.30B
-6.65%1.54B
0.21%1.59B
-1.33%1.55B
-0.83%1.52B
6.77%1.65B
3.93%1.58B
-6.35%1.57B
-11.53%1.53B
-11.05%1.54B
-19.46%1.52B
-18.99%1.68B
27.90%1.73B
30.78%1.73B
46.91%1.89B
62.83%2.08B
11.12%1.36B
53.08%1.33B
Total liabilities
-29.63%554.64M
-26.23%571.81M
-26.13%570.36M
1.56%779.50M
14.03%788.13M
10.07%775.17M
9.84%772.11M
4.51%767.54M
-8.50%691.16M
-22.28%704.26M
-27.10%702.91M
-24.86%734.41M
-36.09%755.38M
-32.62%906.19M
51.28%964.24M
53.03%977.35M
85.62%1.18B
105.39%1.34B
0.29%637.40M
33.62%638.66M
Total equity
-18.11%653.89M
-10.95%693.11M
-2.98%727.21M
-13.82%757.77M
-10.49%798.54M
-10.55%778.35M
-9.86%749.58M
8.82%879.28M
16.16%892.16M
12.27%870.13M
7.98%831.55M
6.79%807.98M
8.24%768.04M
6.11%775.01M
7.17%770.12M
10.11%756.64M
9.03%709.58M
17.87%730.41M
22.90%718.60M
77.04%687.17M
Cash Flow Statement
Net operating income
-27.58%25.68M
31.86%43.69M
12.82%60.83M
-77.44%12.01M
-27.78%35.46M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.10M
13.20%47.58M
4.18%44.44M
45.94%43.50M
-37.85%19.13M
81.08%42.04M
-29.25%42.65M
-1.09%29.81M
154.76%30.78M
-50.25%23.21M
51.55%60.29M
292.87%30.13M
Net investment
175.86%19.44M
5353.53%19.33M
183.61%43.61M
508.56%62.16M
-65.03%-25.63M
-104.39%-368.00K
-1101.36%-52.16M
-307.68%-15.21M
-123.47%-15.53M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-83.28%11.19M
-35.46%-47.52M
531.75%19.16M
-273.70%-208.02M
181.29%66.92M
82.71%-35.08M
-91.60%3.03M
Net financing
-1883.90%-59.40M
-2542.05%-51.65M
-8950.12%-257.48M
-330.20%-57.51M
-6.28%-2.99M
-9.89%-1.96M
89.76%-2.84M
5577.27%24.98M
98.17%-2.82M
96.96%-1.78M
-257.39%-27.79M
100.29%440.00K
15.24%-153.91M
-116.19%-58.51M
-354.75%-7.78M
-2700.83%-153.66M
-1858.69%-181.59M
3387.49%361.41M
-98.54%3.05M
70.55%5.91M

FAQs

What is the total revenue of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its total revenue reached 726.41M, with a year-on-year change of 700.97M.

What are the current assets of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its current assets were 547.97M, with a year-on-year change of -26.46.

What are the total assets of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its total assets of Pacira Biosciences Inc were 1.26B, with a year-on-year change of -18.58.

What are the total liabilities of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its total liabilities of Pacira Biosciences Inc were 571.81M, with a year-on-year change of -26.23.

What is the total equity of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its total equity of Pacira Biosciences Inc was 693.11M, with a year-on-year change of -10.95.

What is the net operating income of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its net operating income of Pacira Biosciences Inc was 36.50M, with a year-on-year change of -62.59.

What is the net investment of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its net investment of Pacira Biosciences Inc was 99.48M, with a year-on-year change of 219.46.

What is the net financing of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its net financing of Pacira Biosciences Inc was -369.63M, with a year-on-year change of -2228.82.

What is the Earnings Per Share (EPS) of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.16, with a year-on-year change of 107.33.

What is the net income of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its net income was 7.03M, with a year-on-year change of 107.07.

What is the net margin of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its net profit margin was 0.97, with a year-on-year change of 106.82.

What is the gross margin of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its gross margin was 71.50, with a year-on-year change of 5.90.

What is the debt-to-asset ratio of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 29.42, with a year-on-year change of -21.91.

What is the Return on Equity (ROE) of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was 0.96, with a year-on-year change of 107.92.

What is the Return on Assets (ROA) of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was 0.50, with a year-on-year change of 107.84.

What is the operating profit of Pacira Biosciences Inc?

According to Pacira Biosciences Inc's FY2025 earnings report, its operating profit was 36.50M, with a year-on-year change of -62.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy